(Q39145133)

9 September 2017

Metabolic Studies in Patients with Nadolol: Oral and Intravenous Administration (English)

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1977.TB04609.X

17 March 2022

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1977.TB04609.X

17 March 2022

author name string

J. Dreyfuss

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A16040

17 March 2022

L. J. Brannick

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A16040

17 March 2022

R. A. Vukovich

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A16040

17 March 2022

J. M. Shaw

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A16040

17 March 2022

D. A. Willard

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A16040

17 March 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16040

17 March 2022

publication date

1 May 1977

1 reference

full work available at URL

9 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fj.1552-4604.1977.tb04609.x

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1977.TB04609.X

http://onlinelibrary.wiley.com/wol1/doi/10.1002/j.1552-4604.1977.tb04609.x/fullpdf

17 March 2022

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1977.TB04609.X

The Journal of Clinical Pharmacology

17 March 2022

published in

1 reference

9 September 2017

17

1 reference

9 September 2017

300-307

1 reference

9 September 2017

5-6

1 reference

Pharmacology of nadolol (SQ 11725), a β-adrenergic antagonist lacking direct myocardial depression

9 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1977.TB04609.X

Anti-arrhythmic action of nadolol, a β-adrenergic receptor blocking agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1977.TB04609.X

21 January 2018

4

15

245

A β-blocking agent (SQ 11,725) that is not metabolized extensively by dogs and monkeys (English)

author name string

Wong

publication date

1973

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1977.TB04609.X

An improved scintillation cocktail of high-solubilizing power

17 March 2022

6

51

173

An improved scintillation cocktail of high-solubilizing power (English)

author name string

Anderson

publication date

1973

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1977.TB04609.X

Propranolol metabolism in man and dog: mass spectrometric identification of six new metabolites

17 March 2022

8

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1977.TB04609.X

16 October 2022

Identifiers

1 reference

9 September 2017

1 reference